Advanced Ketamine & Interventional Mental Health Care

Discover breakthrough treatments for treatment-resistant depression, anxiety, and PTSD with licensed medical providers.

Evidence-Based Treatment Protocols

Explore clinical indications, administration guidelines, and patient monitoring protocols for IV ketamine and FDA-approved Spravato REMS therapy.

Understand commercial insurance coverage, prior authorization criteria, and patient assistance programs for esketamine treatments.

Connect with certified psychiatric medical centers offering safe, physician-supervised interventional treatments in your region.

What is the difference between IV Ketamine and Spravato?: IV ketamine is administered intravenously off-label for depression, while Spravato (esketamine) is an FDA-approved nasal spray covered by many insurance plans.
What conditions are treated with ketamine therapy?: Ketamine and Spravato are clinically indicated for treatment-resistant depression (TRD), major depressive disorder with suicidal ideation, and severe PTSD.
How many sessions are typically required?: An induction protocol usually consists of 6 to 8 treatments over 3-4 weeks, followed by personalized maintenance schedules.

Get in touch with the Kanna team today. We typically respond within one business day.